Biomarker discovery through integrated models of patient metabolic and genetic fingerprints

Biomarker discovery through integrated models of patient metabolic and genetic fingerprints

Biomarker discovery through integrated models of patient metabolic and genetic fingerprints 1125 1625 Metabolism & Cancer
Silibinin mediated HIF 1α inhibition restores oxidative phosphorylation in highly glycolytic nasopharyngeal carcinoma
Nox4 regulates tgf,a-lnduced proliferation and self-renewal in glioblastoma stem cells
The role of adipocyte G0/G1 Switch Gene 2 (G0S2) in the crosstalk between cancer cells and adipocytes
Mitochondrial complex I null cancer models reveal unspecific antiproliferative effects of complex I inhibitors – Copie
Enter your
text here
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.